01 3ACETYLSALICYLIC ACID
02 1ASCORBIC ACID
03 3BILASTINE
04 3BUTALBITAL
05 3CAFFEINE
06 2CODEINE PHOSPHATE
07 1DICLOFENAC POTASSIUM
08 1ISOPROPYL MYRISTATE
09 1NAPROXEN SODIUM
10 1POLYETHYLENE GLYCOL 3350
11 1POTASSIUM CHLORIDE
12 1SODIUM ASCORBATE
13 1SODIUM CHLORIDE
14 1SODIUM SULFATE ANHYDROUS
15 1SUMATRIPTAN (SUMATRIPTAN SUCCINATE)
01 11CAPSULE
02 7POWDER FOR SOLUTION
03 2SOLUTION
04 3TABLET
05 1TABLET (ORALLY DISINTEGRATING)
01 11.015G/SACHET
02 1100G/SACHET
03 110MG
04 115MG
05 12.5MG/ML
06 12.691G/SACHET
07 120MG
08 130MG
09 3330MG
10 14.7G/SACHET
11 340MG
12 15.9G/SACHET
13 150%/W/W
14 1500MG
15 350MG
16 150MG/SACHET
17 17.5G/SACHET
18 185MG
01 3BLEXTEN
02 1CAMBIA
03 3FIORINAL
04 4FIORINAL-C 1/2
05 4FIORINAL-C 1/4
06 6MOVIPREP
07 1RESULTZ
08 2SUVEXX
Regulatory Info : Narcotic (CDSA I)
Registration Country : Canada
Dosage Form : CAPSULE
Dosage Strength : 330MG
Packaging : 100
Brand Name : FIORINAL-C 1/4
Approval Date :
Application Number : 176192
Regulatory Info : Narcotic (CDSA I)
Registration Country : Canada
Regulatory Info : Narcotic (CDSA I)
Registration Country : Canada
Dosage Form : CAPSULE
Dosage Strength : 50MG
Packaging : 100
Brand Name : FIORINAL-C 1/4
Approval Date :
Application Number : 176192
Regulatory Info : Narcotic (CDSA I)
Registration Country : Canada
Regulatory Info : Narcotic (CDSA I)
Registration Country : Canada
Dosage Form : CAPSULE
Dosage Strength : 330MG
Packaging : 100/500
Brand Name : FIORINAL-C 1/2
Approval Date :
Application Number : 176206
Regulatory Info : Narcotic (CDSA I)
Registration Country : Canada
Regulatory Info : Schedule G (CDSA IV)
Registration Country : Canada
Dosage Form : CAPSULE
Dosage Strength : 50MG
Packaging : 100
Brand Name : FIORINAL
Approval Date :
Application Number : 226327
Regulatory Info : Schedule G (CDSA IV)
Registration Country : Canada
Regulatory Info : Schedule G (CDSA IV)
Registration Country : Canada
Dosage Form : CAPSULE
Dosage Strength : 330MG
Packaging : 100
Brand Name : FIORINAL
Approval Date :
Application Number : 226327
Regulatory Info : Schedule G (CDSA IV)
Registration Country : Canada
Regulatory Info : Narcotic (CDSA I)
Registration Country : Canada
Dosage Form : CAPSULE
Dosage Strength : 50MG
Packaging : 100/500
Brand Name : FIORINAL-C 1/2
Approval Date :
Application Number : 176206
Regulatory Info : Narcotic (CDSA I)
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Dosage Form : SOLUTION
Dosage Strength : 2.5MG/ML
Packaging :
Brand Name : BLEXTEN
Approval Date :
Application Number : 2519011
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Dosage Form : TABLET (ORALLY DISINTEGRATING)
Dosage Strength : 10MG
Packaging :
Brand Name : BLEXTEN
Approval Date :
Application Number : 2519038
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Ethical
Registration Country : Canada
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 4.7G/SACHET
Packaging : 1 PCK
Brand Name : MOVIPREP
Approval Date :
Application Number : 2359499
Regulatory Info : Ethical
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Dosage Form : TABLET
Dosage Strength : 20MG
Packaging : 2/10/20/30/40/50
Brand Name : BLEXTEN
Approval Date :
Application Number : 2454130
Regulatory Info : Prescription
Registration Country : Canada
LOOKING FOR A SUPPLIER?